Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
NCT ID: NCT07097298
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2025-07-31
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training?
Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Empathy and (self-)compassion training
A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion. The training will be designed in order to address both self-compassion and compassion. We expect to conduct 1 session at the beginning and 1 session at the end of the program with exercises to do at home for 6 weeks, assigned as tasks based on the needs of patients and their caregivers
empathy and compassion training
A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
empathy and compassion training
A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hoehn and Yahr scale, stage ≤ 3
* Mini Mental State Examination with a score ≥ 26
* Able to give informed consent as documented by signature
* At least, secondary school education
* To have a regular caregiver at home
* Taking care of the patient on a regular basis, i.e., at least 3 days per week
* Being caregiver of the patients for at least 3 months
* At least, secondary school education
* Written informed consent
Exclusion Criteria
* Major depression, dysthymia, or according to DSM-V
* Other neurological or psychiatric diseases
* Neuropsychological scores compatible with the diagnosis of early dementia
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc
For CAREGIVERS:
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CTU-EOC Clinical Trial Unit Ente Ospedaliero Cantonale
UNKNOWN
Alain Kaelin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alain Kaelin
Prof. MD PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC
Lugano, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alain Kaelin, Prof. MD PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EMPCOMP-PD-001
Identifier Type: -
Identifier Source: org_study_id